⌘K

Login Start Free

Home/Filings/4/0001179110-12-005093

4//SEC Filing

Jhoti Harren 4

Accession 0001179110-12-005093

CIK 0000919722other

View on SEC.gov Company Profile

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 4:05 PM ET

Size

9.9 KB

Accession

0001179110-12-005093

Insider Transaction Report

Form 4

Period: 2012-03-13

Astex Pharmaceuticals, IncASTX

DirectorPresident

Transactions

Exercise/Conversion
Common Stock
2012-03-13$0.78/sh+16,084$12,546→ 52,384 total
Exercise/Conversion
Common Stock
2012-03-13$0.84/sh+17,400$14,616→ 69,784 total
Exercise/Conversion
Employee Stock Option (Right to buy)
2012-03-13−16,084→ 0 total
Exercise: $0.78From: 2011-07-20Exp: 2014-07-01→ Common Stock (16,084 underlying)
Exercise/Conversion
Employee Stock Option (Right to buy)
2012-03-13−17,400→ 8,792 total
Exercise: $0.84From: 2011-07-20Exp: 2015-12-01→ Common Stock (17,400 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

Astex Pharmaceuticals, Inc

CIK 0000919722

Entity typeother

Related Parties

1

filerCIK 0001525785

Filing Metadata

Form type: 4
Filed: Mar 14, 8:00 PM ET
Accepted: Mar 15, 4:05 PM ET
Size: 9.9 KB

View on SEC.gov